Sabine
Moravi

Focus

Sabine Moravi brings over 20 years of leadership experience across the global life sciences industry, with a rare combination of executive, investor-facing, and operational expertise. She advises companies ranging from global multinationals to emerging ventures, with a focus on building high-performing, cross-functional teams across commercial and capital markets functions, as well as board governance. Sabine has led a ten-country business with full P&L responsibility and has extensive experience in both IPO and private equity preparation. She has also overseen more than 50 product launches and guided major integrations, including portfolio expansion and organizational redesign.

More…

Sabine has broad therapeutic expertise across oncology, hematology, cardiology, neurology, gastroenterology, dermatology, and aesthetics. She spent nearly two decades in pivotal leadership roles including general management and Investor Relations at Novartis in both Europe and the United States, and later served as Head of Central Europe & Nordics at Galderma, where she led the IPO visibility campaign strategy. She also contributed to Norgine’s private equity readiness process.

She holds a Master in Finance from the University of Graz, Austria, a Healthcare Executive MBA from the University of California, Irvine, and has completed executive education at Harvard. She is board-certified through the Swiss Board School. A dual national of Switzerland and Austria, Sabine is fluent in English and German. She is also Vice-Chair of the Board at the Children’s Tumor Foundation Europe, serves on the Board of Glacies Biome, and was nominated to join the Board of Directors at Arcondis AG.